University of Oxford

State-of-the-Heart
Medicine

Nitric Oxide Nanomedicine for Vascular Healing

We develop next-generation cardiovascular therapeutics — intelligent, nitric oxide-releasing nanomedicines that navigate complex biological environments, respond to pathophysiological stimuli and restore vascular homeostasis.

Discover Our Research Publications Meet the Team
Materials  |  Biology  |  Devices  |  Patients
60+
Publications
3500+
Citations
33
h-index

Key Research Areas

We advance nanomaterial-enabled cardiovascular medicine as a platform for solving unmet clinical challenges; coupling materials design, redox chemical biology and device engineering to accelerate solutions in vascular healing, targeted delivery and real-time diagnosis. Our group cultivates an environment where rigorous science and bold ideas converge.

Catalytic and non-catalytic nitric oxide release

Nitric Oxide Nanomedicine

Designing NO-releasing nanomaterials that restore endothelial function and promote vascular healing.

Learn more →
Targeted drug delivery with NO-releasing graphene

Targeted Drug Delivery

Hypoxia- and redox-responsive carriers that release their payload only where and when it is needed.

Learn more →
Nitric oxide signalling in endothelial, cardiac and immune cells

Nitric Oxide Biology

Decoding how NO governs vascular tone, mitochondrial function and inflammation across cell types.

Learn more →
NO-releasing nanoparticles for cardiovascular devices

Next-Generation Devices

Stents, grafts and vascular implants with controlled, stimulus-responsive drug release.

Learn more →
Dr Tanveer Tabish

Dr Tanveer Tabish

Principal Investigator · Senior Research Fellow & Group Leader, University of Oxford

A cardiovascular nanoscientist working at the interface of nanomaterials, redox chemical biology and biomedical engineering. His work focuses on nitric oxide-releasing nanomedicines for cardiovascular repair, redox-responsive drug carriers, real-time imaging of NO in cells, and next-generation cardiovascular implants, in the Radcliffe Department of Medicine at the University of Oxford.

Oxford Cardiovascular & Redox Nanomedicine Nanomaterials Chemical Biology Fellow, Kellogg College
Full Profile Google Scholar

Latest News

November
2026

🧬 Three Fully Funded DPhil Projects

We have three DPhil projects on offer through the BHF Oxford Centre of Research Excellence and the BHF Oxford–Cambridge VascularRewind Programme. Applications close 1 December 2026.

More Details →
2026

NANOCARD Programme

Our cardiovascular nanotherapeutics programme spans materials, biology, devices and patients — from NO-releasing coatings to first-in-class vascular implants.

2026

Join the Group

We welcome enquiries from prospective PhD students, postdoctoral researchers and fellowship candidates interested in cardiovascular nanomedicine.

Get in Touch →
All News & Events →

Get in touch

Interested in collaboration, PhD opportunities, or joining the group? We'd love to hear from you.

Submit form

Our location

📍 Radcliffe Department of Medicine
John Radcliffe Hospital
University of Oxford
Oxford, OX3 9DU, UK
Oxford Profile →